| RS2519031306 |
GSS
|
Health Risk |
Pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519033349 |
GSS
|
Health Risk |
Pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519036298 |
GSS
|
Health Risk |
Likely pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519036640 |
GSS
|
Health Risk |
Likely pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519039652 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS2519043780 |
GSS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutathione synthetase deficiency without 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519043873 |
GSS
|
Health Risk |
Pathogenic |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS2519049277 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519049304 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519049357 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519049362 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519049376 |
NR0B1
|
Health Risk |
Pathogenic/Likely pathogenic |
NR0B1-related disorder, Congenital adrenal hypoplasia |
| RS2519050843 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519050868 |
NR0B1
|
Health Risk |
Pathogenic |
NR0B1-related disorder, NR0B1-related disorder |
| RS2519051075 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051116 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051128 |
NR0B1
|
Health Risk |
Likely pathogenic |
— |
| RS2519051194 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051223 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051351 |
NR0B1
|
Health Risk |
Pathogenic |
NR0B1-related disorder, NR0B1-related disorder |
| RS2519051360 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051412 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051604 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051714 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051723 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051880 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS2519051933 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519051970 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519052221 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519052283 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS2519053431 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519053484 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519053637 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519056022 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519056187 |
NAGA
|
Health Risk |
Likely pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519056409 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency |
| RS2519056669 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519056930 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519057308 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2519057505 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519058015 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519058491 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2519059881 |
DMD
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2519061179 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519061488 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519064275 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519064379 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519065479 |
NAGA
|
Health Risk |
Likely pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519065527 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS2519067593 |
DEPDC5
|
Health Risk |
Likely pathogenic |
— |
| RS2519073881 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2519083192 |
CNKSR2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2519091663 |
IL1RAPL1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 21 |
| RS2519093 |
ABO
|
Health Risk |
association |
ABO blood group system, ABO blood group system |
| RS2519094101 |
IL1RAPL1
|
Health Risk |
Pathogenic |
— |
| RS2519098517 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519099220 |
ARX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519099293 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519099311 |
ARX
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS2519099351 |
ARX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519099357 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519099414 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519099802 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS2519101342 |
CNKSR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked |
| RS2519101408 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519101445 |
ARX
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519101659 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2519101744 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519101904 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519101958 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519104168 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519106563 |
ARX
|
Health Risk |
Likely pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS2519107008 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519107067 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS2519107209 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519107237 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS2519107284 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519107314 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519107521 |
ARX
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2519109094 |
ARX
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked |
| RS2519109392 |
ARX
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2519111000 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519111064 |
EBP
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS2519111356 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2519111380 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2519111447 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2519112476 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2519115447 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2519115726 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519121172 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519121332 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2519122368 |
TUBGCP6
|
Health Risk |
Likely pathogenic |
Microcephaly and chorioretinopathy 1, Microcephaly and chorioretinopathy 1 |
| RS2519123259 |
CACNA1F
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2519124587 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2519124670 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS2519124859 |
MAOA
|
Health Risk |
Likely pathogenic |
— |
| RS2519125510 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519128240 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519128471 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2519130860 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |